- Why are vegetarians more likely to suffer from depression than meat eaters?
- Small wireless device implanted between skin and skull helps kill cancer cells
- Will the mRNA vaccine that can cure cancer come out near soon?
- Allogeneic T-cell therapy set for landmark first approval
- Boston University denies that the new COVID strain they made has 80% fatality rate
- A new generation of virus-free CAR-T cell therapy
Can breast atypical ductal hyperplasia cause breast cancer?
- First human trial of HIV gene therapy: A one-time cure will be achieved if successful!
- New breakthrough in CAR-T cell therapy: Lupus erythematosus patients achieved treatment-free remission for up to 17 months
- How long can the patient live after heart stent surgery?
- First time: Systemic multi-organ recovery after death
- Where do the bacteria in the human gut come from?
Can breast atypical ductal hyperplasia cause breast cancer? Breast atypical ductal hyperplasia is considered a benign disease, but it does not rule out the possibility of breast cancer.
Atypical ductal hyperplasia (ADH) refers to the number of cells in the lining of the breast ducts than usual. These cells have some low-grade ductal carcinoma in situ (DCIS) characteristics in terms of growth pattern and appearance. ADH is a benign breast disease, but there is still a risk of breast cancer.
If you have a core biopsy that found atypical cells, your doctor may continue to remove more tissue in the area. However, since ADH is not a real cancer, there may be some changes in how doctors treat them.
Some doctors believe that after the initial biopsy is confirmed, no additional surgery is needed. Whether to remove the hyperplastic part must be carried out according to the specific situation.
For ADH, you can consult other doctors to give a second diagnosis and treatment opinion, and ask other pathologists to check tissue samples. It is worth noting that atypical hyperplasia is not early breast cancer.
Regardless of your condition, it makes sense to be followed up by a doctor with expertise in breast health. Usually, a follow-up physical examination is performed at 6 months, and mammograms can be recommended. After that, most women can recover annual mammograms. Under certain circumstances, the doctor may increase breast MRI.
For some women, doctors may recommend hormone therapy such as tamoxifen, raloxifene, or aromatase inhibitors to reduce the risk of breast cancer.
Studies have found that most ADH cells are positive for estrogen and progesterone receptors.
However, these treatments have side effects, so your personal circumstances will determine whether the benefits outweigh the risks.
(source:internet, reference only)